Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ, 2014. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60: 1268–1289.
Bragazzi MC, Cardinale V, Carpino G, Venere R, Semeraro R, Gentile R, Gaudio E, Alvaro D, 2012. Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer 1: 21–32.
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, 2002. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 3: 1–781.
Banales JM et al. 2016. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13: 261–280.
Palmer WC, Patel T, 2012. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57: 69–76.
Sakoda LC et al. 2006. Prostaglandinendoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27: 1251–1256.
Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD, 2004. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99: 523–526.
Hoblinger A, Grunhage F, Sauerbruch T, 2009. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer. Digestion 80: 36–39.
Huang WY et al. 2008. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a populationbased case-control study in China. Carcinogenesis 29: 100–105.
Khan SA, Toledano MB, Taylor-Robinson SD, 2008. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10: 77–82.
Lesurtel M, Regimbeau JM, Farges O, Colombat M, Sauvanet A, Belghiti J, 2002. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in western countries. Eur J Gastroenterol Hepatol 14: 1025–1027.
Lipshutz GS, Brennan TV, Warren RS, 2002. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 195: 713–718.
Tyson GL, El-Serag HB, 2011. Risk factors of cholangiocarcinoma. Hepatology 54: 173–184.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100: 1–441.
Fedorova OS et al. 2016. Opisthorchis felineus infection and cholangiocarcinoma in the Russian Federation: a review of medical statistics. Parasitol Int 16: 30236–30237.
Zvonareva O, Odermatt P, Golovach EA, Fedotova MM, Kovshirina YV, Kovshirina AE, Kobyakova OS, Fedorova OS, 2017. Life by the river: neglected worm infection in western Siberia and pitfalls of a one-size-fits-all control approach. Crit Public Health 28: 1–12.
Kaewpitoon N, Kaewpitoon SJ, Pengsaa P, Sripa B, 2008. Opisthorchis viverrini: the carcinogenic human liver fluke. World J Gastroenterol 14: 666–674.
Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, Bethony JM, Loukas A, 2012. The tumorigenic liver fluke Opisthorchis viverrini—multiple pathways to cancer. Trends Parasitol 28: 395–407.
Sripa B, Pairojkul C, 2008. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24: 349–356.
Srivatanakul P, Ohshima H, Khlat M, Parkin M, Sukarayodhin S, Brouet I, Bartsch H, 1991. Endogenous nitrosamines and liver fluke as risk factors for cholangiocarcinoma in Thailand. IARC Sci Publ: 88–95.
Gouveia MJ et al. 2017. Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model. Carcinogenesis 38: 929–937.
Brazhnikova NA, Tolkaeva MV, 2002. Rak pecheni, zhelchnyh putej i podzheludochnoj zhelezy pri hronicheskom opistorhoze. Byull Sib Med 2: 7–77.
Bugaeva T, Ivanov PM, Alekseeva MN, Odintsova IN, Boyarkina AP, 2009. Pervichnyj rak pecheni v respublike Saha (Jakutija). Sib Oncol J 32: 44–48.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 992 | 832 | 303 |
Full Text Views | 1387 | 15 | 0 |
PDF Downloads | 568 | 14 | 0 |
Cholangiocarcinoma (CCA) is a cancer with high mortality owing to its aggressiveness and resistance to therapy. The liver flukes of the Opisthorchiidae family have been recognized as risk factors of CCA. Opisthorchis felineus infection occurs in Western Siberia, the biggest endemic area in the Russian Federation, and is associated with chronic inflammation of the bile ducts, which may be linked to severe hepatobiliary morbidity. We report two cases of confirmed CCA who had a chronic O. felineus infection. Both cases presented unspecific symptoms at the onset of the disease, a stage when severe pathological changes already had occurred. Both patients were living in endemic areas but did not receive any antihelminthic treatment. This report underlines the need for assessment of O. felineus infection as a causative factor of CCA. The results will provide further arguments for control of O. felineus in the Russian Federation.
Financial support: This work was supported by the Russian Science Foundation (“Metabolic changes in the parasite-host interaction at the organ and organism level,” N14-15-00247, to O. S. F., L. M. O.) and grant of Tomsk State University (“Relationship between opisthorchiasis and cholangiocarcinoma in Western Siberia: case-control study,” N7407, to Yu. V. K., A. E. K., A. V. C., S. V. O.).
Ethical approval: Study procedures followed the ethical standards of the Helsinki Declaration of the World Medical Association. Ethical Approval was obtained from the Ethical Committee of Siberian State Medical University (N4384, November 30, 2015). Patient’s written informed consent was obtained. All information was anonymized.
Authors’ addresses: Yulia V. Kovshirina, Department of Infectious Diseases and Epidemiology, Federal State Budget Educational Institution of Higher Education, Siberian State Medical University, Ministry of Healthcare of Russian Federation, Tomsk, Russian Federation, E-mail: yulia.v.kovshirina@gmail.com. Olga S. Fedorova, Anna E. Kovshirina, and Ludmila M. Ogorodova, Department of Faculty Pediatrics, Federal State Budget Educational Institution of Higher Education, Siberian State Medical University, Ministry of Healthcare of Russian Federation, Tomsk, Russian Federation, E-mails: olga.sergeevna.fedorova@gmail.com, annutakovshirina@gmail.com, and osf77@list.ru. Sergey V. Vtorushin, Department of Pathology, Federal State Budget Educational Institution of Higher Education, Siberian State Medical University, Ministry of Healthcare of Russian Federation, Tomsk, Russian Federation, E-mail: wtorushin@rambler.ru. Stanislav D. Ivanov, Department of Faculty Pediatric, Federal State Budget Educational Institution of Higher Education, Siberian State Medical University, Ministry of Healthcare of Russian Federation, Tomsk, Russian Federation, E-mail: ivanov_st@mail.ru. Andrey V. Chizhikov, Department of Oncology, Radiology, and Radiotheraphy, Budget Institution of Higher Education of Khanty-Mansiysk Autonomous Okrug, Khanty-Mansiysk State Medical Academy, Khanty-Mansiysk, Russian Federation, E-mail: tchandrey@mail.ru. Sergey V. Onishchenko, Department of Hospital Surgery, Budget Institution of Higher Education of Khanty-Mansiysk Autonomous Okrug, Surgut State University, Surgut, Russian Federation, E-mail: sergej-on@mail.ru. Peter Odermatt, Department Public Health and Epidemiology, Swiss Tropical Institute, Basel, Switzerland, and Department Public Health and Epidemiology, University of Basel, Basel, Switzerland, E-mail: peter.odermatt@unibas.ch.
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ, 2014. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60: 1268–1289.
Bragazzi MC, Cardinale V, Carpino G, Venere R, Semeraro R, Gentile R, Gaudio E, Alvaro D, 2012. Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer 1: 21–32.
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, 2002. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 3: 1–781.
Banales JM et al. 2016. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13: 261–280.
Palmer WC, Patel T, 2012. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57: 69–76.
Sakoda LC et al. 2006. Prostaglandinendoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis 27: 1251–1256.
Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD, 2004. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99: 523–526.
Hoblinger A, Grunhage F, Sauerbruch T, 2009. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer. Digestion 80: 36–39.
Huang WY et al. 2008. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a populationbased case-control study in China. Carcinogenesis 29: 100–105.
Khan SA, Toledano MB, Taylor-Robinson SD, 2008. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10: 77–82.
Lesurtel M, Regimbeau JM, Farges O, Colombat M, Sauvanet A, Belghiti J, 2002. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in western countries. Eur J Gastroenterol Hepatol 14: 1025–1027.
Lipshutz GS, Brennan TV, Warren RS, 2002. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 195: 713–718.
Tyson GL, El-Serag HB, 2011. Risk factors of cholangiocarcinoma. Hepatology 54: 173–184.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100: 1–441.
Fedorova OS et al. 2016. Opisthorchis felineus infection and cholangiocarcinoma in the Russian Federation: a review of medical statistics. Parasitol Int 16: 30236–30237.
Zvonareva O, Odermatt P, Golovach EA, Fedotova MM, Kovshirina YV, Kovshirina AE, Kobyakova OS, Fedorova OS, 2017. Life by the river: neglected worm infection in western Siberia and pitfalls of a one-size-fits-all control approach. Crit Public Health 28: 1–12.
Kaewpitoon N, Kaewpitoon SJ, Pengsaa P, Sripa B, 2008. Opisthorchis viverrini: the carcinogenic human liver fluke. World J Gastroenterol 14: 666–674.
Sripa B, Brindley PJ, Mulvenna J, Laha T, Smout MJ, Mairiang E, Bethony JM, Loukas A, 2012. The tumorigenic liver fluke Opisthorchis viverrini—multiple pathways to cancer. Trends Parasitol 28: 395–407.
Sripa B, Pairojkul C, 2008. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 24: 349–356.
Srivatanakul P, Ohshima H, Khlat M, Parkin M, Sukarayodhin S, Brouet I, Bartsch H, 1991. Endogenous nitrosamines and liver fluke as risk factors for cholangiocarcinoma in Thailand. IARC Sci Publ: 88–95.
Gouveia MJ et al. 2017. Infection with Opisthorchis felineus induces intraepithelial neoplasia of the biliary tract in a rodent model. Carcinogenesis 38: 929–937.
Brazhnikova NA, Tolkaeva MV, 2002. Rak pecheni, zhelchnyh putej i podzheludochnoj zhelezy pri hronicheskom opistorhoze. Byull Sib Med 2: 7–77.
Bugaeva T, Ivanov PM, Alekseeva MN, Odintsova IN, Boyarkina AP, 2009. Pervichnyj rak pecheni v respublike Saha (Jakutija). Sib Oncol J 32: 44–48.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 992 | 832 | 303 |
Full Text Views | 1387 | 15 | 0 |
PDF Downloads | 568 | 14 | 0 |